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S U M M A R Y
Objectives: The aims of this study were to describe the epidemiological features and clinical
characteristics of infective endocarditis (IE) at a tertiary-care hospital in Japan and to identify the
factors associated with in-hospital mortality.
Methods: A retrospective observational study was conducted at a 925-bed tertiary-care teaching
hospital in Japan. All adult patients diagnosed with deﬁnite IE between August 2000 and July
2014 according to the modiﬁed Duke criteria were included.
Results: A total of 180 patients (60.6% men; mean age, 69.1 years) with deﬁnite IE were included. The
most common pathogen was Staphylococcus aureus (27.2%). Nine patients (5.0%) had culture-negative IE.
Transthoracic and transoesophageal echocardiography were performed in 180 (100%) and 132 patients
(73.3%), respectively, and vegetations were detected in 128 patients (71.1%). Surgical therapy was
performed in 31 patients (17.2%). Overall, the in-hospital mortality rate was 26.1%. The independent
predictors of in-hospital mortality were methicillin-resistant S. aureus (MRSA), vascular phenomena,
health care-associated IE and heart failure.
Conclusions: MRSA, vascular phenomena, health care-associated IE and heart failure were independent
predictors of in-hospital mortality. The unique characteristics in our cohort were the very high mean age,
low rate of culture-negative IE, high rate of deﬁnite IE without detected vegetations and predominance of
S. aureus.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Background
Infective endocarditis (IE) has a high mortality rate.1–3 Its
characteristics and causative pathogens differ by country and have
changed over time.4–6 The increasing opportunities of contact with
pathogens in the health care setting and the use of invasive procedures
are important reasons for the variations in causative pathogens.7
To improve the outcome of this highly lethal disease, the early
identiﬁcation of patients who are at a high risk of mortality is
important. Although several studies6,8–15 have evaluated possible* Corresponding author. Present address: Department of Infectious Diseases,
Kameda Medical Center, 929 Higashicho, Kamogawa, Chiba 2968602, Japan.
Tel.: +81-4-7092-2211; fax: +81-4-7099-1198.
E-mail address: ryota510@hotmail.com (R. Hase).
http://dx.doi.org/10.1016/j.ijid.2015.01.003
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).predictors of mortality in patients with IE, reports from Japan are
scarce.
We conducted this study to describe the epidemiological
features and clinical characteristics of IE in a tertiary-care hospital
in Japan and to identify the factors associated with in-hospital
mortality.
2. Methods
2.1. Study design and setting
This retrospective cohort study was conducted at Kameda
Medical Center, a large tertiary-care teaching hospital with
925 beds, in Japan. The study was approved by the Committee
for Ethics of Kameda Medical Center under the condition that
personal data be kept conﬁdential. Because of the retrospective,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Summary of patients’ demographics, clinical characteristics, therapy and outcomes
(n = 180)
Variables (n = 180)
Mean age, years (SD) 69.1 (14.0)
Sex, men, n (%) 109 (60.6)
Comorbidities, n (%)
Diabetes 25 (13.8)
Cancer 15 (8.3)
Glucocorticoid use 11 (6.11)
Haemodialysis 19 (10.6)
Conditions, n (%)
Shock 21 (11.7)
Altered mental status 35 (19.4)
Heart failure 50 (27.8)
Vascular phenomena 107 (59.4)
Immunological phenomena 51 (28.3)
Persistent bacteraemia 107 (59.4)
Echocardiogram and vegetation ﬁndings, n (%)
Performance of TTE 180 (100)
Performance of both TTE and TEE 132 (73.3)
Vegetation detected by TTE 97 (53.9)
Vegetation detected either by TTE or TEE 128 (71.1)
Aortic valve 58 (32.2)
Mitral valve 76 (42.2)
Pulmonic valve 1 (0.6)
Tricuspid valve 1 (0.6)
Multi 11 (6.1)
Others 5 (2.8)
Type of IE, n (%)
Prosthetic valve involvement 35 (19.4)
Community acquired 106 (58.9)
Non-nosocomial health care associated 47 (26.1)
Nosocomial health care associated 27 (15.0)
Treatment and Outcome, n (%)
Appropriate empirical antimicrobial therapy 70 (38.9)
Surgery 31 (17.2)
In-hospital mortality 47 (26.1)
SD: standard deviation; TTE: transthoracic echocardiogram, TEE: transoesophageal
echocardiogram
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consent was waived.
2.2. Participant selection
Patients diagnosed with IE between August 2000 and July
2014 were potentially eligible for study inclusion. We extracted
information for these patients from the electronic medical record
and our department database. The clinical information regarding
these patients was retrospectively obtained from the electronic
medical records. The modiﬁed Duke criteria16 were used to screen
deﬁnite IE cases, and possible IE cases were excluded.
2.3. Deﬁnition of variables
The demographic data obtained were age, gender and
comorbidities, such as diabetes, cancer, the use of glucocorticoids,
haemodialysis and prosthetic valve involvement. Diabetes was
considered present when it was listed in the patient record as a co-
morbid condition or if the patient’s HbA1c (Japan Diabetes Society)
was >6.2%, which is equivalent to HbA1c (National Glycohemo-
globin Standardization Program) >6.6%. Cancer was considered
present when patients had any active disease or if they had
received chemotherapy for cancer. Glucocorticoid users were
deﬁned as those receiving an equivalent of 10 mg of prednisolone
for >1 month. Haemodialysis use was considered present if a
patient had undergone maintenance haemodialysis.
Information regarding clinical characteristics, including the
presence of shock, altered mental status, heart failure, persistent
bacteraemia, vascular phenomena, immunological phenomena,
vegetations and causative pathogens, was also obtained. Shock was
deﬁned as a systolic blood pressure <90 mmHg that did not
recover after intravascular volume resuscitation. The Framingham
criteria17 were used to diagnose chronic heart failure. Persistent
bacteraemia was deﬁned as at least two positive blood cultures
obtained on different calendar days during the same infectious
episodes.18 Vascular phenomena include major arterial emboli,
septic pulmonary infarcts, mycotic aneurysms, intracranial hae-
morrhages, conjunctival haemorrhages and Janeway lesions.
Immunological phenomena included glomerulonephritis, Osler’s
nodes, Roth spots and rheumatoid factor positivity. Vascular and
immunological phenomena were considered negative when no
ﬁndings of these phenomena were documented. Vegetations were
considered to be present when detected by either transthoracic
echocardiography (TTE) or transoesophageal echocardiography
(TEE). The location of the vegetations was documented when it was
speciﬁed in the records.
IE was classiﬁed according to the mode of acquisition on the
basis of the deﬁnitions in a previous study.7 Community-acquired
IE was that diagnosed at the time of admission or 48 h of
admission in patients not fulﬁlling the criteria for health care-
associated IE. Health care-associated IE was subclassiﬁed into
nosocomial IE or non-nosocomial health care-associated IE.
Nosocomial IE was that developing in patients hospitalized for
>48 h before the onset of signs or symptoms of IE. Non-nosocomial
health care-associated IE was that diagnosed 48 h of admission in
outpatients with extensive health care contact, as evidenced by
one the following criteria: (1) if they received intravenous therapy,
wound care or specialized nursing care at home 30 days before IE
onset; (2) if they attended a hospital or haemodialysis clinic and/or
had received intravenous chemotherapy 30 days before IE onset;
(3) if they were hospitalized in an acute care hospital for 2 days in
the 90 days before IE onset; or (4) if they resided in a nursing home
or long-term care facility.
Appropriate empirical antimicrobial therapy was deﬁned as
the empirical administration of antimicrobials to which thesubsequently isolated pathogens had in vitro susceptibility before
the ﬁrst report of microbiology cultures. If the causative pathogen
was not detected, empirically administered antimicrobial agents
that were recommended after consultation with the Infectious
Diseases department were regarded as appropriate. These
recommendations were usually based on either the American
Heart Association guidelines19 or the European Society of
Cardiology guidelines.20 Patients were considered to have
undergone surgical therapy if it was performed during the
course of antimicrobial treatment. In-hospital mortality was
chosen as an outcome variable.
2.4. Statistical analysis
The odds ratio for in-hospital mortality was calculated with 95%
conﬁdence intervals for each variable of interest in univariate
logistic regression. All variables with theoretical clinical impor-
tance and those that achieved a P value of <0.10 in the univariate
analysis were included in the multivariate analysis. A backward
stepwise method was used to select most useful predictors of the
outcome. All analyses were performed using the R version 3.0.2.
(http://www.r-project.org) with the EZR frontend.21
3. Results
In total, 180 patients were diagnosed with deﬁnitive IE and were
treated during the study period. A summary of the patients’
demographics, clinical characteristics, therapy and outcome is
presented in Table 1. The mean age of the patients was 69.1 years,
and 109 patients (60.6%) were men. The most common comorbidity
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were observed in 50 (27.8%), 35 (19.4%) and 21 patients (11.7%),
respectively. Vascular phenomena (59.4%) were more common than
immunological phenomena (28.3%). Persistent bacteraemia was
observed in 107 patients (59.4%). TTE and TEE were performed in
180 (100%) and 132 patients (73.3%), respectively. Vegetations were
detected by TTE in 97 patients (53.9%) and by either TTE or TEE in
128 patients (71.1%). The most commonly involved valve was the
mitral valve (42.2%), followed by the aortic valve (32.2%). IE
involving the prosthetic valves was observed in 35 patients (19.4%).
Community-acquired IE was diagnosed in 106 patients (58.9%), non-
nosocomial health care-associated IE was diagnosed in 47 (26.1%),
and nosocomial health care-associated IE was diagnosed in
27 patients (15.0%).
Causative pathogens are listed in Table 2. The most common
causative pathogen was S. aureus in 49 patients (27.2%), followed
by viridans streptococci in 40 patients (22.2%), coagulase-negative
staphylococci in 21 patients (11.7%), Enterococcus faecalis in
14 patients (7.8%), b-haemolytic streptococci in 11 patients
(6.1%), Enterobacteriaceae in 11 patients (6.1%), Streptococcus
anginosus group in 10 patients (5.6%) and other pathogens,
including Pseudomonas spp., Corynebacterium spp., Granulicatella
adiacens, Streptococcus bovis, Abiotrophia sp., Gemella morbillorum,
Propionibacterium acnes, Actinobacillus actinomycetemcomitans and
Weissella confusa, in 15 patients (8.3%). Nine patients (5.0%) had
culture-negative IE, including two patients with Bartonella henselae
infection, as detected by the polymerase chain reaction on DNA
isolated from a surgically removed valve. Sixty-eight patients
(37.8%) received appropriate empirical antimicrobial therapy as
per our deﬁnition. Surgical therapy was performed in 31 patients
(17.2%). Overall, 47 patients died before discharge, and the in-
hospital mortality rate was 26.1%.
Variables identiﬁed as signiﬁcant predictors of in-hospital
mortality in the univariate analyses were age 70 years, diabetes,
haemodialysis, shock, altered mental status, heart failure, vascular
phenomena, methicillin-resistant S. aureus (MRSA), viridans strep-
tococci, prosthetic valve involvement and health care-associated IE.Table 2
Acquisition of infective endocarditis and causative organisms (n = 180)
Causative organism Community
acquired
(n = 106)
Health care
associated
(Non-
nosocomial)
(n = 47)
Health care
associated
(Nosocomial)
(n = 27)
Total
(n = 180)
Staphylococcus aureus 19 14 16 49
MSSA 16 8 10 34
MRSA 3 6 6 15
Viridans streptococci 35 5 0 40
CNS 7 9 5 21
Enterococcus faecalis 9 3 2 14
b-haemolytic
streptococci
8 3 0 11
Enterobacteriaceae 3 6 2 11
Streptococcus
anginosus group
9 1 0 10
Unknown 5 2 0 7
Pseudomonas spp. 2 2 0 4
Corynebacterium spp. 1 0 2 3
Bartonella henselae 2 0 0 2
Granulicatella adiacens 1 1 0 2
Streptococcus bovis 1 0 0 1
Abiotrophia sp. 1 0 0 1
Gemella morbillorum 1 0 0 1
Propionibacterium acnes 0 1 0 1
Actinobacillus
actinomycetemcomitans
1 0 0 1
Weissella confusa 1 0 0 1
MSSA: methicillin-susceptible Staphylococcus aureus; MRSA: methicillin-resistant
Staphylococcus aureus; CNS: coagulase-negative staphylococciThese eleven variables were included in the ﬁnal multivariable
logistic regression model. As presented in Table 3, heart failure,
vascular phenomena, MRSA and health care-associated IE were
independently associated with in-hospital mortality.
4. Discussion
We conducted a retrospective cohort study to describe the
epidemiological and clinical features of IE and to identify factors
associated with in-hospital mortality in patients admitted to a
tertiary-care hospital in Japan. The study demonstrated that the
mean age of the patients was 69.1 years, S. aureus was the most
common causative pathogen, surgical therapy was performed in
17.2% patients and the in-hospital mortality rate was 26.1%. We
also found that MRSA, vascular phenomena, health care-associated
IE and heart failure were independent predictors of in-hospital
mortality.
Routine consultation for all patients with positive blood culture
with regular inpatient and outpatient infectious diseases consul-
tation services was implemented in 2005 at our institution. As a
result of this proactive intervention, improved IE detection rate
and a decreased IE relapse rate within 6 months were achieved.22
At our institution, a total of 180 patients have been diagnosed with
IE and treated in the past 14 years. Although a web-based survey
involving 118 hospitals [CArdiac Disease REgistration-Infective
Endocarditis (CADRE-IE)] has reported the details of 513 cases,23 to
date, our study is the largest single-centre study of deﬁnite IE
conducted in Japan.
The mean age of patients in our cohort was 69.1 years. IE
appears to affect the elderly population in developed countries.
The mean patient age in our cohort was higher than that in the
International Collaboration on Endocarditis–Prospective Cohort
Study (ICE-PCS) (57.9 years), the largest cohort study of IE
worldwide,6 and CADRE-IE (61 years), the largest cohort study
of IE in Japan.23 This very high mean age in our cohort reﬂects the
typical demographics in rural areas in Japan.
Although our cohort did not include a conﬁrmed case of IE in
intravenous drug users, the most common causative pathogen was
S. aureus. The predominance of S. aureus was consistent with the
recent trend observed in developed countries.6,7 However, viridans
streptococci were the most common pathogens in the CADRE-IE
cohort.23 This discrepancy may be explained by our proactive
infectious diseases consultation service, which improved the
detection of IE among patients with positive blood culture. Many
IE cases in our cohort were diagnosed under this service in patients
with S. aureus bacteraemia, and the same result was reported from
another hospital in the US.24
Culture-negative IE accounted only for 5.0% patients in our
cohort, even though culture-negative IE has accounted for a mean
of 10% patients in ICE-PCS6 and 20% patients in CADRE-IE.23
Although we experienced two cases of B. henselae infection,
fastidious microorganisms, such as Bartonella spp., Brucella spp.
and Coxiella burnetii, are rarely reported in Japan. Although clear
data were not collected, the high rate of blood culture performance
and low rate of antimicrobial use before diagnosis also contributed
to this low rate of culture-negative endocarditis. In addition, our
proactive infectious diseases consultation service for patients with
bacteraemia was considered to affect the rate of culture-negative
IE by improving the detection of IE among patients with
bacteraemia.
Vegetations were detected in only 71.1% patients in our cohort.
This incidence was lower than the rates of 87.0% and 90.2%
reported in ICE-PCS6 and CADRE-IE,23 respectively. Low perfor-
mance rate of TEE could be a reason for low detection of
vegetations; however, 73.3% patients in our cohort underwent
TEE, which was higher than the rate of 59.0% reported in ICE-PCS.6
Table 3
Univariate and multivariate analyses of predictors for in-hospital death
Univariate analysis Multivariate analysis
Risk factors OR (95% CI) P value OR (95% CI) P value
Age
<70 reference
70 2.89 (1.34–6.53) 0.004
Sex ratio (men:women) 0.84 (0.41–1.76) 0.608
Comorbidities
Diabetes 2.58 (0.97–6.75) 0.047
Cancer 1.46 (0.37–5.02) 0.543
Corticosteroid use 1.06 (0.17–4.69) 1.000
Haemodialysis 4.72 (1.59–14.65) 0.002
Conditions
Shock 4.67 (1.66–13.69) 0.001
Altered mental status 4.19 (1.80–9.89) <0.001
Heart failure 3.27 (1.52–7.09) 0.001 3.50 (1.53–8.00) 0.003
Persistent bacteraemia 1.14 (0.55–2.40) 0.733
Vascular phenomena 3.31 (1.46–8.10) 0.002 5.05 (1.99–12.80) <0.001
Immunological phenomena 0.83 (0.35–1.84) 0.708
Vegetation present 0.94 (0.43–2.13) 0.854
Organisms
MRSA 13.00 (3.21–76.4) <0.001 11.4 (2.63–49.70) 0.001
MSSA 1.23 (0.48–2.97) 0.666
CNS 0.87 (0.23–2.69) 1.000
Viridans streptococci 0.32 (0.09–0.91) 0.025
Enterococcus faecalis 0.76 (0.13–3.05) 1.000
Prosthetic valve implantation 0.41 (0.12–1.17) 0.088
Health care associated 4.02 (1.90–8.79) <0.001 4.40 (1.90–10.20) <0.001
Appropriate empirical antimicrobial therapy 1.23 (0.59–2.54) 0.603
Surgical therapy 0.49 (0.14–1.42) 0.186
OR: odds ratio; CI: conﬁdence interval; MRSA: methicillin-resistant Staphylococcus aureus; MSSA: methicillin-susceptible Staphylococcus aureus; CNS: coagulase-negative
staphylococci
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consultation service for positive blood culture actively identiﬁed
patients meeting other Duke criteria to facilitate a diagnosis even
when vegetations were not detected by TEE. In fact, patients
without detected vegetations were diagnosed with deﬁnite IE on
the basis of one major criterion (positive blood culture for infective
endocarditis) and three minor criteria of the modiﬁed Duke
criteria.
Surgical therapy was performed in 17.2% patients in our cohort,
which was signiﬁcantly lower than the rates of 48.2% and 61%
reported in ICE-PCS and CADRE-IE, respectively. This low
percentage of surgical therapy may be explained by several
factors. First, the relatively large number of patients without
detected vegetations in our cohort limited the number of patients
indicated for surgical therapy. As discussed above, vegetations
were not detected in 28.9% patients in our cohort. Second, none of
the patients in our cohort was transferred for the purpose of
surgical therapy. This lack of referral patients with surgical
indication may have decreased the percentage of patients
requiring surgical therapy. Most patients with IE were diagnosed
in our hospital; therefore, our cohort included many patients who
did not fulﬁl the indication for surgical therapy. On the other hand,
other large multi-centre cohorts included many patients who were
referred for surgical therapy. Third, elderly patients in our cohort
may have been relatively less likely considered for surgical
therapy.
The overall in-hospital mortality rate was 26.1%, which was
higher than the rates of 18% reported in ICE-PCS6 and 16% reported
in CADRE-IE.23 Because early surgery is believed to be an effective
treatment option to decrease mortality in stable patients with IE
and large vegetations,25 it is possible that this discrepancy is
explained by the low rate of surgical treatment in our cohort.
However, as noted above, the small number of referral patients
suitable for surgical therapy, age of the population and the
predominance of S. aureus may explain the higher mortality rate.Multivariate analysis in our study identiﬁed MRSA, vascular
phenomena, health care-associated IE and heart failure as
independent predictors of in-hospital mortality. Among these
four factors, MRSA had the highest odds ratio. Some studies have
also conﬁrmed that these factors were associated with in-hospital
mortality.9,15,26–28 However, other studies identiﬁed other signiﬁ-
cant factors associated with in-hospital mortality, such as
increasing age, prosthetic valve involvement, coagulase-negative
staphylococcal infection, mitral valve vegetations, paravalvular
complications and diabetes mellitus.3,29 These discrepancies may
be because of the lack of uniformity of variables and differences in
study design.
Our study has some limitations. First, this study is single-centre
study; therefore, our patient population does not precisely reﬂect
the general demographics in Japan. Second, the small number of
events resulted in relatively wide, albeit statistically signiﬁcant,
conﬁdence intervals. Thus, another study with a larger number of
patients is required to conﬁrm the predictors for in-hospital
mortality.
In conclusion, our study demonstrated that IE remains a highly
lethal disease in the elderly population in Japan, and that it is
associated with high in-hospital mortality rates. MRSA, vascular
phenomena, health care-associated IE and heart failure were
independent predictors of in-hospital mortality. The low rate of
culture-negative IE, high rate of deﬁnite IE without detected
vegetations and the predominance of S. aureus were unique
ﬁndings in our cohort; these characteristics were inﬂuenced by our
proactive infectious diseases consultation service for patients with
bacteraemia.
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